Skip to main content
NCBI home page
Journal of the National Medical Association logoLink to Journal of the National Medical Association
. 1994 Jan;86(1):46–52.

Modified bovine surfactant (Survanta) versus a protein-free surfactant (Exosurf) in the treatment of respiratory distress syndrome in preterm infants: a pilot study.

S S Sehgal 1, C K Ewing 1, T Richards 1, H W Taeusch 1
PMCID: PMC2607653  PMID: 8151722

Abstract

We undertook a prospective, randomized, non-blinded pilot study to determine whether infants with respiratory distress syndrome (RDS) who were treated with protein-containing bovine surfactant (Survanta, Ross/Abbott Laboratories, Columbus, Ohio) had earlier and larger responses in gas exchange when compared with similar infants treated with a synthetic surfactant (Exosurf, Burroughs Wellcome, Research Triangle Park, North Carolina). Forty-one infants weighing between 600 g and 1750 g at birth with RDS of sufficient severity to require assisted ventilation with an FiO2 > 0.39 were enrolled in the study and treated with surfactant from 1 to 8 hours after birth. Infants were randomly selected to receive treatment with either Exosurf or Survanta. Despite randomization, the Survanta group was overrepresented with factors associated with greater severity of RDS (lower birthweight, more males, and fewer African Americans). No statistically significant difference was found in the primary outcome measure (arterial/alveolar PaO2 > 0.3 at 24 hours) by univariate or multivariate analysis. The percentage of responders in the Survanta-treated group was significantly increased 24 hours after treatment in two of four secondary measures of oxygenation when analyzed by univariate tests using one-tailed P values. Based on these results, we anticipate that acute outcomes after Survanta or Exosurf will approximate those found in this trial and that differences in measures of oxygenation between treatment groups will approximate 30% to 50% 24 hours after initial treatment.

Full text

PDF
46

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Corbet A., Bucciarelli R., Goldman S., Mammel M., Wold D., Long W. Decreased mortality rate among small premature infants treated at birth with a single dose of synthetic surfactant: a multicenter controlled trial. American Exosurf Pediatric Study Group 1. J Pediatr. 1991 Feb;118(2):277–284. doi: 10.1016/s0022-3476(05)80502-5. [DOI] [PubMed] [Google Scholar]
  2. Gitlin J. D., Soll R. F., Parad R. B., Horbar J. D., Feldman H. A., Lucey J. F., Taeusch H. W. Randomized controlled trial of exogenous surfactant for the treatment of hyaline membrane disease. Pediatrics. 1987 Jan;79(1):31–37. [PubMed] [Google Scholar]
  3. Hellström-Westas L., Bell A. H., Skov L., Greisen G., Svenningsen N. W. Cerebroelectrical depression following surfactant treatment in preterm neonates. Pediatrics. 1992 Apr;89(4 Pt 1):643–647. [PubMed] [Google Scholar]
  4. Horbar J. D., Soll R. F., Sutherland J. M., Kotagal U., Philip A. G., Kessler D. L., Little G. A., Edwards W. H., Vidyasagar D., Raju T. N. A multicenter randomized, placebo-controlled trial of surfactant therapy for respiratory distress syndrome. N Engl J Med. 1989 Apr 13;320(15):959–965. doi: 10.1056/NEJM198904133201502. [DOI] [PubMed] [Google Scholar]
  5. Liechty E. A., Donovan E., Purohit D., Gilhooly J., Feldman B., Noguchi A., Denson S. E., Sehgal S. S., Gross I., Stevens D. Reduction of neonatal mortality after multiple doses of bovine surfactant in low birth weight neonates with respiratory distress syndrome. Pediatrics. 1991 Jul;88(1):19–28. [PubMed] [Google Scholar]
  6. McCord F. B., Curstedt T., Halliday H. L., McClure G., Reid M. M., Robertson B. Surfactant treatment and incidence of intraventricular haemorrhage in severe respiratory distress syndrome. Arch Dis Child. 1988 Jan;63(1):10–16. doi: 10.1136/adc.63.1.10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Papile L. A., Burstein J., Burstein R., Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr. 1978 Apr;92(4):529–534. doi: 10.1016/s0022-3476(78)80282-0. [DOI] [PubMed] [Google Scholar]
  8. Segerer H., Stevens P., Schadow B., Maier R., Kattner E., Schwarz H., Curstedt T., Robertson B., Obladen M. Surfactant substitution in ventilated very low birth weight infants: factors related to response types. Pediatr Res. 1991 Dec;30(6):591–596. doi: 10.1203/00006450-199112000-00022. [DOI] [PubMed] [Google Scholar]
  9. Soll R. F., Hoekstra R. E., Fangman J. J., Corbet A. J., Adams J. M., James L. S., Schulze K., Oh W., Roberts J. D., Jr, Dorst J. P. Multicenter trial of single-dose modified bovine surfactant extract (Survanta) for prevention of respiratory distress syndrome. Ross Collaborative Surfactant Prevention Study Group. Pediatrics. 1990 Jun;85(6):1092–1102. [PubMed] [Google Scholar]
  10. van de Bor M., Ma E. J., Walther F. J. Cerebral blood flow velocity after surfactant instillation in preterm infants. J Pediatr. 1991 Feb;118(2):285–287. doi: 10.1016/s0022-3476(05)80503-7. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the National Medical Association are provided here courtesy of National Medical Association

RESOURCES